Conformational Transitions of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor, a Human Class B GPCR
Abstract The G protein-coupled pituitary adenylate cyclase-activating polypeptide receptor (PAC1R) is a potential therapeutic target for endocrine, metabolic and stress-related disorders. However, many questions regarding the protein structure and dynamics of PAC1R remain largely unanswered. Using m...
Main Authors: | Chenyi Liao, Xiaochuan Zhao, Matthias Brewer, Victor May, Jianing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-05815-x |
Similar Items
-
Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
by: Gabriella Horvath, et al.
Published: (2022-04-01) -
Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
by: João C. R. Cardoso, et al.
Published: (2020-05-01) -
Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system
by: Aki Oride, et al.
Published: (2018-07-01) -
On the existence of possible pituitary adenylate cyclase-activating polypeptide adenylate type 1 receptor in earthworms
by: L Molnár, et al.
Published: (2015-06-01) -
On the existence of possible pituitary adenylate cyclase-activating polypeptide adenylate type 1 receptor in earthworms
by: L Molnár, et al.
Published: (2015-05-01)